List of works by Nicolas Penel

"Classical 3 + 3 design" versus "accelerated titration designs": analysis of 270 phase 1 trials investigating anti-cancer agents.

scientific article published on 10 January 2009

"Impossible" patients in oncology: Two unusual cases

scientific article published on 27 June 2018

A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome.

scientific article published on 20 December 2017

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

scientific article

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

scientific article published on 06 January 2020

A noninterventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma.

scientific article published on 18 September 2017

A paradigm shift in tumour response evaluation of targeted therapy: the assessment of novel drugs in exploratory clinical trials

scientific article published on May 2012

A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors.

scientific article published on 11 November 2012

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

scientific article

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy.

scientific article published on 20 October 2017

A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosa.

scientific article published on 21 July 2006

A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.

scientific article published on 28 April 2009

Activity endpoints reported in soft tissue sarcoma phase II trials: quality of reported endpoints and correlation with overall survival.

scientific article published on 22 May 2013

Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis

scientific article published on 19 November 2007

Adjuvant radiation therapy in metastatic lymph nodes from melanoma

scientific article

Adult desmoid tumors: biology, management and ongoing trials.

scientific article

Advanced Abrikossoff tumour: a metastatic or a multifocal malignancy?

scientific article published on 11 July 2011

Advanced chondrosarcomas: role of chemotherapy and survival.

scientific article published on 07 October 2013

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).

scientific article

Angiosarcoma: state of the art and perspectives.

scientific article

Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study

scientific article published on 3 June 2015

Are there criteria for the diagnosis of paraneoplastic fever?

scientific article published on August 2000

Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordoma

scientific article

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.

scientific article

Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)

scientific article published on 22 June 2018

Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis.

scientific article

Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis

scientific article published on 21 August 2007

Cancer-associated hypercalcemia: validation of a bedside prognostic score

scientific article published on 17 March 2009

Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.

scientific article published on 10 February 2004

Chondrosarcoma of the femur in Mazabraud's syndrome: A first case study

scientific article published on 20 October 2015

Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapy

scientific article published on 07 May 2010

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO).

scientific article

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.

scientific article

Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.

scientific article published in November 2011

Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis.

scientific article published on 9 December 2014

Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective stud

scientific article published on 5 November 2016

Crossed views of burden and emotional distress of cancer patients and family caregivers during palliative care.

scientific article published on 3 December 2015

Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?

scientific article published on April 2012

Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals

scientific article published on 07 August 2020

Determining the length of posttherapeutic follow-up for cancer patients using competing risks modeling

scientific article published on 27 June 2013

Development and validation of a bedside score to predict early death in cancer of unknown primary patients

scientific article

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics

article

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)

scientific article published on 12 February 2020

Development of a score that predicts survival among patients with bone metastasis revealing solid tumor

scientific article published on 14 May 2008

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis

scientific article

Dose-Response Relationship in Phase I Clinical Trials: A European Drug Development Network (EDDN) Collaboration Study

article

Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials

scientific article

Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma.

scientific article published in June 2010

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol

scientific article published on 18 June 2019

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

scientific article

Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group.

scientific article published on 7 October 2014

Efficacy and safety of 153Sm-EDTMP as treatment of painful bone metastasis: a large single-center study.

scientific article

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group

scientific article

Erratum

Factors determining length of the postoperative hospital stay after major head and neck cancer surgery

scientific article published on 01 November 2007

Factors favouring palliative treatment multidisciplinary decisions for newly diagnosed visceral and soft tissue sarcomas.

scientific article published on 28 April 2008

Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients

scientific article published on 18 September 2009

Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502)

scientific article published on 20 January 2010

First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control

scientific article published on 20 January 2016

First-line management of metastatic castrate-resistant prostate cancer patients: Audit of real-life practices

scientific article published on 5 April 2017

Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases

scientific article published on January 2008

Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials.

scientific article

Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics

scientific article

Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors

scientific article published on 12 January 2018

Genotyping of a family with a novel deleterious DPYD mutation supports the pretherapeutic screening of DPD deficiency with dihydrouracil/uracil ratio.

scientific article published on 11 August 2015

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

scientific article

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

scientific article

Head and neck cancer surgery in the elderly--does age influence the postoperative course?

scientific article published on 29 December 2009

Head and neck soft tissue sarcomas of adult: prognostic value of surgery in multimodal therapeutic approach.

scientific article published in October 2004

Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis

scientific article published on 31 August 2019

How to emerge from the conservatism in clinical research methodology?

scientific article

How to report toxicity associated with targeted therapies?

scientific article

Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship?

scientific article published on 4 March 2011

Imatinib as a possible cause of severe rhabdomyolysis

scientific article published in June 2008

Imatinib in gastrointestinal stromal tumor: does treatment duration matter?

scientific article published on 04 September 2009

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial

scientific article published on 05 March 2018

Improved survival using specialized multidisciplinary board in sarcoma patients

scientific article published on 01 November 2017

Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study

scientific article published on 2 April 2015

Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients.

scientific article published on 9 May 2009

Inappropriate dose of multitargeted tyrosine kinase inhibitors: the original sin.

scientific article

Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients

scientific article

Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary.

scientific article published on 30 March 2010

Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: illustration over a 20-year period

scientific article published on 16 February 2012

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

scientific article published on 11 February 2015

Is adjuvant chemotherapy useful in lobular breast cancer patients?

scientific article published on 23 June 2011

Life-expectancy of patients enrolled in phase 1 clinical trials: a systematic review of published prognostic models.

scientific article published on 09 January 2012

Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO)

scientific article published on 08 September 2012

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy

scientific article published on 02 June 2018

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

scientific article

Long-term recurrence of soft tissue sarcomas: Prognostic factors and implications for prolonged follow-up

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial

scientific article published on 12 November 2013

L’année 2015 à travers le regard du comité de rédaction du Bulletin du cancer

scholarly article by Nicolas Magné et al published January 2016 in Bulletin du Cancer

Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).

scientific article published on 26 January 2016

Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literature.

scientific article published on 11 April 2012

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

scientific article

Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.

scientific article

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

scientific article

Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review

scientific article published on 23 November 2017

Metabolic disorders associated with the use of targeted cancer therapies.

scientific article

Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome

scientific article published on 12 May 2011

Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.

scientific article

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

scientific article

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial.

scientific article published on 20 March 2018

Nomogram to predict treatment outcome of fluoropyrimidine/platinum-based chemotherapy in metastatic esophageal squamous cell carcinoma.

scientific article published on 31 December 2013

Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.

scientific article published on 16 March 2018

O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.

scientific article published on 13 June 2008

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

scientific article published on 31 July 2018

Oral metronomic cyclophosphamide in elderly with metastatic melanoma

scientific article published on 12 August 2009

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

scientific article published on 28 June 2018

Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database

scientific article published on 7 March 2014

PRognostic factor of Early Death In phase II Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model).

scientific article

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

scientific article published on 27 July 2015

Pain burden in desmoid tumor patients: a survey of the French Advocacy Group SOS Desmoid.

scientific article published on 3 March 2015

Participation in randomised clinical trials is linked to emotion regulation strategies.

scientific article published on 15 September 2010

Patient selection for oncology phase I trials: a multi-institutional study of prognostic factors.

scientific article published on 21 February 2012

Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

scientific article published on 19 July 2019

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (

article

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma

scientific article published on 04 December 2020

Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer

scientific article

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

scientific article

Phase II trials in patients with carcinoma of unknown primary: a pooled data analysis

scientific article

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

scientific article

Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study

scientific article published on December 2010

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

scientific article published in August 2017

Predictive value of clinical judgment of tumour progression in phase II trials

scientific article

Predictors for establishing recommended phase 2 doses: analysis of 320 dose-seeking oncology phase 1 trials.

scientific article published on 4 November 2010

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

scientific article

Previous chemotherapy as a predictor of wound infections in nonmajor head and neck surgery: Results of a prospective study

scientific article published on 01 June 2004

Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.

scientific article

Primary mucosal melanoma of head and neck: prognostic value of clear margins.

scientific article

Primitive neuroectodermal tumour of the duodenum with unexpected lymph node involvement

scientific article published on 01 January 2008

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

scientific article published on 11 October 2018

Prognostic factors among cancer patients with good performance status screened for phase I trials

scientific article published on 22 September 2007

Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks setting

scientific article published on 10 July 2014

Prognostic factors for adult sarcomas of head and neck

scientific article published on 14 March 2008

Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study.

scientific article published on September 2004

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study

scientific article published on 21 August 2019

Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR.

scientific article

Proposal for size justification of expanded cohort at phase-2-recommended dose.

scientific article published on 2 February 2010

Prostate cancer and DNA repair genes

scientific article published on 9 October 2017

Prostate cancer related haemophagocytic syndrome: successful treatment with chemotherapy

scientific article published on 22 September 2011

Psychosocial factors involved in delayed consultation by patients with head and neck cancer.

scientific article published in April 2005

Pulmonary blastoma in adult: dramatic but transient response to doxorubicin plus ifosfamide

scientific article published on 29 July 2010

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib

scientific article published on 01 April 2020

REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis

scientific article published on 10 March 2017

Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients.

scientific article published in November 2011

Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)

scientific article published on 31 May 2018

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas

scientific article published on 07 February 2014

Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma G

article

Reappraisal of eligibility criteria in cancer clinical trials

scientific article published on 01 September 2018

Regorafenib use as a possible cause of intestinal perforation

scientific article published on 12 September 2013

Reply to B. Biswas and D. Dabkara.

scientific article published on 28 December 2015

Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patients

scientific article published on 7 June 2016

Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study

scientific article published on 19 July 2019

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy

scientific article

Risk factors for early catheter-related infections in cancer patients

scientific article published in October 2007

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

scientific article published on 14 October 2016

Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years

scientific article published on 15 April 2019

Selection of ultimately ill cancer patients able to fulfill a questionnaire: Identification of inherent biases.

scientific article published on 30 July 2015

Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.

scientific article

Silent hereditary hematochromatosis as a susceptibility factor of doxorubicin-induced acute cardiac failure

scientific article published on 11 October 2010

Soft tissue sarcoma associated with chronic lymphocytic leukemia: about 5 cases

scientific article published on 30 September 2005

Soft tissue sarcomas or intramuscular haematomas?

scientific article published on 10 June 2009

Solitary fibrous tumors and so-called hemangiopericytoma.

scientific article published on 8 April 2012

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

scientific article published on 27 January 2012

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study.

scientific article published on 02 June 2016

Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).

scientific article published on 15 April 2013

Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO).

scientific article published on 5 September 2013

Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group

scientific article

Statistical controversies in clinical research: should schedules of tumor size assessments be changed?

scientific article

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

scientific article

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

scientific article published on 20 July 2017

Switch in use of midazolam for cancer patients during the COVID-19 pandemic

scientific article published on 14 August 2020

Targeting angiogenesis in advanced soft tissue sarcoma: tivozanib-hype or me-too?

scientific article published on 01 January 2017

Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years.

scientific article published on 23 December 2010

The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors

scientific article published on 20 March 2014

The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patients

scientific article published on 01 July 2018

The off-label use of targeted therapies in sarcomas: the OUTC'S program

scientific article

The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value

scientific article

Time interval between surgery and start of adjuvant radiotherapy in patients with soft tissue sarcoma: A retrospective analysis of 1131 cases from the French Sarcoma Group

scientific article

Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.

scientific article published on 9 August 2011

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

scientific article

Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group

scientific article

Trabectedin is an effective second-line treatment in soft tissue sarcoma patients

scientific article published on 24 November 2015

Treatment of adult patients with metastatic sarcoma: current shift in concepts

scientific article published on June 2010

Tumor calcification: a new response pattern of myxoid liposarcoma to trabectedin.

scientific article published on January 2014

Tumor lysis syndrome with symptomatic hyperuricemia after a first chemotherapeutic treatment of undifferentiated carcinoma of the cavum

scientific article

Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders

scientific article published on 31 May 2019

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial

scientific article

Usefulness of social and educational approach in adolescents and young adults with cancer: The Lille team's experience

scientific article published on 22 November 2016

Vinorelbine in breast cancer

scientific article published on 01 November 2008

What does a modified-Fibonacci dose-escalation actually correspond to?

scientific article

What is an active regimen in carcinoma of unknown primary sites? Analysis of correlation between activity endpoints reported in phase II trials. Correlation of activity endpoints in phase II trials.

scientific article published on April 2014

When cancerophobia and denial lead to death

scientific article published on 01 June 2009

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

scientific article published on 17 June 2016

[2017 ASCO: Complete androgen blockade strikes back].

scientific article

[ASCO 2016: Confirmation of respective roles of docetaxel and cabazitaxel in prostate cancer patients].

scientific article

[Adjuvant chemotherapy for upper tract urothelial cancer: Level of evidence IA]

scientific article published on 17 September 2018

[An index of understanding randomised clinical trials in oncology]

scientific article published on 01 June 2009

[Anti-PLD1 and anti-PD1 in advanced urothelial cancers: promises from early phase trials].

scientific article

[Association soft tissue sarcoma and familial adenomatous polyposis: a case-report].

scientific article

[Autoimmune hypophysitis associated with new anti-cancer immunotherapies].

scientific article published on 20 February 2018

[Before seasonal influenza, vaccination of cancer patients and healthcare givers]

scientific article published on 30 January 2019

[Cancer screening words]

scientific article published on 16 April 2019

[Carcinoma of unknown primary site: From necropsy to epigenetic analysis].

scientific article published on 29 November 2016

[Clinical equipoise and randomised clinical trials in oncology]

scientific article published on 01 June 2009

[Definitions of target volumes in soft tissue sarcomas of the extremities]

scientific article published on 01 October 2001

[Dermatofibrosarcoma: Management]

scientific article published on 05 October 2018

[Docetaxel and prostate cancer: Early but not too early].

scientific article published on 30 July 2015

[Evolution of the regulatory framework in clinical research]

scientific article published on 15 March 2019

[French Sarcoma Group proposals for management of sarcoma patients during COVID-19 outbreak]

scientific article published on 01 April 2020

[Merkel cell carcinoma: current diagnosis and treatment]

scientific article published on 01 September 2008

[Methodological approaches of clinical studies with targeted therapies]

scientific article published on 01 February 2008

[Phase 1 of clinical trial: The issue of dose-escalating]

scientific article published on 01 June 2016

[Phases 0, 1 and 2 oncology clinical trials: current questions]

scientific article published on 01 January 2010

[Primary leiomyosarcoma of pulmonary artery: a rare tumor mis-diagnosed as pulmonary embolism]

scientific article published on 01 January 2003

[Primary soft tissue sarcoma of the chest in adults: a retrospective study of 40 cases]

scientific article published on 01 May 2003

[Prognosis of post-irradiation soft-tissue sarcoma: case-control study]

scientific article published on 01 December 2004

[Prognostic and predictive factors of soft tissue sarcoma: a daily use of translational research]

scientific article published on 01 April 2009

[Renal colic due to kidney metastase from larynx cancer]

scientific article published on 01 January 2003

[Requirement of DPD deficiency screening before prescription of fluoropyrimidines]

scientific article published on 01 April 2018

[Soft sarcoma tissue of extremities: medical imagery in post-therapeutic follow-up]

scientific article published on 21 November 2005

[Soft tissue sarcoma: role of imaging for initial diagnosis and treatment]

scientific article published on 18 November 2005

[Soft tissue sarcomas: Questions about reported clinical benefit].

scientific article published on 15 September 2015

[Splicing variant of androgen receptors (AR-V7): New paradigms].

scientific article

[Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3].

scientific article

[Ultra-late metastasis of ocular melanoma: about two cases]

scientific article published on 01 February 2004

[What role for the direct oral anticoagulants in oncology?]

scientific article published on 28 June 2018

[Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board]

scientific article published on 19 December 2016

[β-catenin and desmoid tumors: The ideal biomarker?]

scientific article published on 20 December 2016

irRECIST and iRECIST: the devil is in the details

scientific article published on 01 July 2017

Paulina is supported by:

About Paulina

Help